`
Wednesday, 16 August 2017

Singapore News

  • Singapore's ASLAN pharma inks MoU with NCCS

    Singapore |  News | By BioSpectrum Bureau | 0 Comment | 20 Jul, 2015

    Singapore: ASLAN Pharmaceuticals has inked a memorandum of understanding with Singapore's National Cancer Center (NCCS) to develop newer therapies and intensify research of novel agents for...Read more

  • Singapore study indentifies new type of lymphoma

    Singapore |  News | By BioSpectrum Bureau | 0 Comment | 15 Apr, 2013

    Singapore: Researchers at the lymphoma study group at Singapore General Hospital (SGH) and the National Cancer Center of Singapore (NCCS) have identified a new type of deadly intestinal lym...Read more

  • NUS develops smart hand rehabilitation device

    Singapore |  News | By BioSpectrum Bureau | 0 Comment | 13 Jan, 2016

    Singapore: Research team from National University of Singapore (NUS) has developed a new lightweight and smart rehabilitation device called EsoGlove for the patients who have lost their han...Read more

  • Agilent, A*Star, French univ sign biologics MoU

    Singapore |  News | By BioSpectrum Bureau | 0 Comment | 27 May, 2013

    Singapore: Agilent Technologies, Glyco-MEV laboratory at the University of Rouen, France, and Bioprocessing Technology Institute (BTI) at the Agency for Science, Technology and Research (A*...Read more

  • Asia an emerging hotspot in medical tourism

    Singapore |  Analysis | By Aishwarya Venkatesh | 0 Comment | 09 Mar, 2015

    Singapore: BioSpectrum feels the pulse of Asia's top destinations and major players in medical tourism.  Medical tourism industry is growing worldwide. Frost and Sullivan predicts that t...Read more

  • Sanofi gears up to introduce dengue vaccine

    Singapore |  Influencers | By Amrita Tejasvi | 0 Comment | 15 Aug, 2014

    Healthcare stakeholders are keeping high hopes with the successful results of Sanofi Pasteur's Phase III trial of dengue vaccine completed this year and a vaccine may be available soon. The...Read more

  • A*Star, SigN use patients' own blood to treat infection

    Singapore |  News | By BioSpectrum Bureau | 0 Comment | 30 Sep, 2013

    Singapore: Scientists at A*Star's Singapore Institute for Clinical Sciences (SICS) and the Singapore Immunology Network (SigN) have used patients' own blood to treat infection. This has led...Read more

  • DKSH partners with Bristol-Myers Squibb

    Singapore |  News | By BioSpectrum Bureau | 0 Comment | 09 Apr, 2014

    Singapore: DKSH Business Unit Healthcare, service provider for healthcare companies seeking to grow their business in Asia, has extended the relationship started in 2010 with Bristol-Myers ...Read more

  • HIMSS AsiaPac 2015 strives to integrate IT and healthcare

    Singapore |  News | By BioSpectrum Bureau | 0 Comment | 08 Sep, 2015

    Singapore: Singapore Minister for Health, Mr Gan Kim Yong, kickstarted HIMSS AsiaPac15 Digital Healthcare Week in Singapore on Sep 7, a gathering of clinical professionals and IT experts to...Read more

  • Acumen, Curetis to jointly advance on biomarker panel for immune system

    Singapore |  News | By BioSpectrum Bureau | 0 Comment | 09 Oct, 2015

    Singapore: Germany based Curetis, a developer of next-level molecular diagnostic solutions, has obtained a world-wide, non-exclusive license to AcuSept, a proprietary biomarker panel from S...Read more

  • Innovations in 3D printing

    Singapore |  Analysis | By Amrita Tejasvi | 0 Comment | 25 Nov, 2014

    Singapore: Here's a look at some of the lastest innovations in 3D printing: Stratasys: US-based company is developing a range of material properties from rigid to flexible and opaque to tr...Read more

  • BI takes crowdfunding approach to boost research

    Singapore |  News | By BioSpectrum Bureau | 0 Comment | 23 Sep, 2015

    Singapore: Boehringer Ingelheim and BioMed X have applied a crowdsourcing approach to establish a research team of outstanding scientists from around the world with bright ideas, who will e...Read more

  • Singapore medtech startup launches in Hong Kong

    Singapore |  News | By BioSpectrum Bureau | 0 Comment | 28 Aug, 2015

    Singapore: Singapore-based medtech start up ConneXion Asia has launched its services in Hong Kong. The launch comes after the company raised $8 million in Series A funding in early February...Read more

  • Agilent launches training centre in Singapore

    Singapore |  News | By BioSpectrum Bureau | 0 Comment | 07 Oct, 2015

    Singapore: Agilent Technologies has opened a training facility in Singapore, named as Agilent University, to provide technology courses for Agilent customers and field support engineers fro...Read more

  • Future of security in healthcare

    Singapore |  News | By BioSpectrum Bureau | 0 Comment | 04 Aug, 2015

    Singapore: According to the global consulting firm Tower Watson, Singapore has one of the most successful healthcare systems in the world, in terms of both efficiency in financing and the r...Read more

  • Singapore's CGH launches new robotics center

    Singapore |  News | By BioSpectrum Bureau | 0 Comment | 23 Jul, 2015

    Singapore: In a bid to promote the use of robotics and assistive technologies in advancing healthcare, Singapore's Changi General Hospital (CGH) has opened a new center for robotics-the Cen...Read more

  • CROs and pharma support 'Bring Your Own Device' approach for clinical studies: ICON survey

    Singapore |  News | By BioSpectrum Bureau | 0 Comment | 04 Jul, 2016

    Singapore: ICON, a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, has conducted a research that revealed that...Read more

  • Mundipharma to market Korea's Medifoam

    Singapore |  News | By BioSpectrum Bureau | 0 Comment | 03 Jun, 2014

    Singapore: Singapore based pharmaceutical company, Mundipharma has collaborated with Korean firm Genewel for licensing and promotion of its Medifoam (marketed as BETAplast outside Korea), a...Read more

Survey Box

Does Asia have more to offer to the global 3D cell culture market?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls